Onclive articles Copyright (c) 2009 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Tue, 30 Sep 2014 15:53:06 EDT 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Dr. Saab on a Phase II Study of the Oncolytic Virus Reolysin for Pancreatic Cancer]]>http://www.onclive.com/conference-coverage/esmo-2014/Dr-Saab-on-a-Phase-II-Study-of-the-Oncolytic-Virus-Reolysin-for-Pancreatic-CancerOnclive articlesusTue, 30 Sep 2014 17:07:11 EDTOnclive<![CDATA[Durable Responses Observed with Nivolumab in Previously Treated mRCC]]>http://www.onclive.com/conference-coverage/esmo-2014/Durable-Responses-Observed-with-Nivolumab-in-Previously-Treated-mRCCOnclive articlesusTue, 30 Sep 2014 15:36:01 EDTOnclive<![CDATA[New Data Provides Insight Into Optimal Pre-Chemo Treatments for mCRPC]]>http://www.onclive.com/conference-coverage/esmo-2014/New-Data-Provides-Insight-Into-Optimal-Pre-Chemo-Treatments-for-mCRPCOnclive articlesusTue, 30 Sep 2014 15:27:43 EDTOnclive<![CDATA[Dabrafenib/Trametinib Combo Improves Survival Over Vemurafenib in Phase III COMBI-v Trial]]>http://www.onclive.com/conference-coverage/esmo-2014/DabrafenibTrametinib-Combo-Improves-Survival-Over-Vemurafenib-in-Phase-III-COMBI-v-TrialOnclive articlesusTue, 30 Sep 2014 13:04:22 EDTOnclive<![CDATA[Expanded Mutation Analysis Fails to Resolve Targeted Therapy Quandary in Metastatic CRC]]>http://www.onclive.com/conference-coverage/esmo-2014/Expanded-Mutation-Analysis-Fails-to-Resolve-Targeted-Therapy-Quandary-in-Metastatic-CRCOnclive articlesusTue, 30 Sep 2014 12:49:47 EDTOnclive<![CDATA[Dr. Motzer on a Phase II Trial of Nivolumab for mRCC]]>http://www.onclive.com/conference-coverage/esmo-2014/Dr-Motzer-on-a-Phase-II-Trial-of-Nivolumab-for-mRCCOnclive articlesusTue, 30 Sep 2014 10:45:27 EDTOnclive<![CDATA[Combination BRAF, MEK Inhibition “New Standard” for Previously Untreated BRAF-Mutant Melanoma]]>http://www.onclive.com/conference-coverage/esmo-2014/Combination-BRAF-MEK-Inhibition-New-Standard--for-Previously-Untreated-BRAF-Mutant-MelanomaOnclive articlesusMon, 29 Sep 2014 14:16:41 EDTOnclive<![CDATA[Pembrolizumab Shows Promise in Advanced Gastric Cancer]]>http://www.onclive.com/conference-coverage/esmo-2014/Pembrolizumab-Shows-Promise-in-Advanced-Gastric-CancerOnclive articlesusMon, 29 Sep 2014 14:11:11 EDTOnclive<![CDATA[Crizotinib Highly-Effective in ROS1-Rearranged NSCLC]]>http://www.onclive.com/conference-coverage/esmo-2014/Crizotinib-Highly-Effective-in-ROS1-Rearranged-NSCLCOnclive articlesusMon, 29 Sep 2014 13:58:01 EDTOnclive<![CDATA[Dr. Weber on Nivolumab Versus Chemotherapy in Advanced Melanoma]]>http://www.onclive.com/conference-coverage/esmo-2014/Dr-Weber-on-the-Results-of-a-Phase-III-Study-of-Nivolumab-vs-Chemotherapy-in-Advanced-MelanomaOnclive articlesusMon, 29 Sep 2014 10:31:22 EDTOnclive